Connecticut 2022 2022 Regular Session

Connecticut Senate Bill SB00364 Introduced / Fiscal Note

Filed 04/29/2022

                    OFFICE OF FISCAL ANALYSIS 
Legislative Office Building, Room 5200 
Hartford, CT 06106  (860) 240-0200 
http://www.cga.ct.gov/ofa 
SB-364 
AN ACT CONCERNING HEALTH INSURANCE. 
AMENDMENT 
LCO No.: 5942 
File Copy No.: 315 
Senate Calendar No.: 234  
 
Primary Analyst: MP 	4/29/22 
Contributing Analyst(s): CP, RJW 	(NF) 
 
 
 
 
OFA Fiscal Note 
See Fiscal Note Details  
The amendment strikes the underlying bill and its associated fiscal 
impact and results in the fiscal impacts described below.  
State Reinsurance Program 
The amendment requires the Office of Health Strategy (OHS) to seek 
a Section 1332 state innovation waiver to establish a reinsurance 
program designed to lower premiums for the individual health 
insurance market. The amendment specifies that if the waiver is 
granted, the Treasurer must annually pay the amount needed to fund 
the program, up to $21.21 million, and that the Health Reinsurance 
Association (HRA) will administer it.
1
  This results in the following 
fiscal impacts: 
• a General Fund cost of up to $21.21 million per year beginning 
in FY 24 to fund the state reinsurance program, conditional on 
a federally approved 1332 waiver being in place, 
 
1
 HRA is an existing nonprofit association that all health insurers, health care centers, 
and self-insurers must belong to as a condition of offering health insurance in 
Connecticut. Depending on the reinsurance program’s complexity, the annual cost for 
HRA to administer the program is estimated to range from $150,000 to $500,000, which 
is the cost for a third-party administrator to manage the reinsurance program 
operations (e.g. processing claims).  2022SB-00364-R00LCO05942-FNA.DOCX 	Page 2 of 3 
 
 
• a cost to OHS of at least $100,000 in FY 23 for a consultant to 
apply for the waiver,  
• an annual revenue gain of federal funding, beginning in FY 
24 or later, and 
• a potential change to state insurance premiums tax revenue.  
Generally, Section 1332 waiver programs generate significant new 
state revenue from the federal government (known as "pass-through" 
funding) which can partially fund a state's program. The actual revenue 
gain will depend on how much the program reduces federal premium 
tax credits for Connecticut Health Insurance Exchange enrollees.
2
  Any 
such revenue would be received annually while the waiver was in effect, 
after the waiver was applied for and approved. 
A reinsurance program may change the total amount of net direct 
premiums written in Connecticut, and through that, may change 
collections of the state's 1.5% insurance premiums tax. Lower direct 
written premiums, due to per-policy cost reductions from reinsurance, 
would proportionately lower tax revenue, but increased enrollment, 
due to lower prices, may offset any such direct written premium 
reductions. The Department of Revenue Services collected $202.3 
million from the Insurance Premiums Tax in FY 21; it is uncertain how 
much of that revenue is from policies that could be affected by the 
reinsurance provision under the amendment. 
Pharmacy Benefit Managers (PBM) Report 
The amendment also results in a potential cost of up to $500,000 to 
the Insurance Department in FY 23. The amendment requires the 
Insurance Department (DOI) to prepare and submit a report to the 
Insurance and Real Estate Committee by January 1, 2023, which must 
include an analysis of PBMs' use of spread pricing arrangements, 
 
2
https://www.cms.gov/CCIIO/Programs-and-Initiatives/State-Innovation-
Waivers/Section_1332_State_Innovation_Waivers-
#Application%20Tools%20and%20Resources  2022SB-00364-R00LCO05942-FNA.DOCX 	Page 3 of 3 
 
 
manufacturing rebates and transparency and accountability. If the 
agency can collect sufficiently detailed information from PBMs as 
would be required for an in-depth analysis, it is anticipated that DOI 
would hire a consultant with expertise in drug pricing and PBM drug 
distribution practices to prepare the report at a cost of up to $500,000. 
The cost would depend on the complexity of the analysis. 
State Purchasing Pools Report 
The provisions requiring the Department of Public Health and State 
Comptroller to prepare and submit a report have no fiscal impact since 
the agencies have enough expertise within existing staff resources to 
conduct the study. 
 
The preceding Fiscal Impact statement is prepared for the benefit of the members of the General Assembly, solely 
for the purposes of information, summarization and explanation and does not represent the intent of the General 
Assembly or either chamber thereof for any purpose. In general, fiscal impacts are based upon a variety of 
informational sources, including the analyst’s professional knowledge. Whenever applicable, agency data is 
consulted as part of the analysis, however final products do not necessarily reflect an assessment from any 
specific department.